New research uncovers role of p38alpha in mood disorders, addiction

Aug 11 2011

Stressful experiences increase addictive drug consumption and can precipitate bouts of anxiety or depression in vulnerable people. Although the mechanisms linking stress and human behaviors are not well understood, animal models of some aspects of these behaviors have been developed and have been used to define some of the molecular events that may be responsible for stress vulnerability in people. The goal of these studies is to identify potential new therapeutics that may enhance stress resilience. Now, new research, published by Cell Press in the August 11 issue of the journal Neuron, uncovers a previously unappreciated role for p38alpha, a mitogen-activated protein kinase better known for its role in cellular stress, in the regulation of mood disorders, and risk for addiction.

Recent research has suggested that in addition to regulating cell death and differentiation, p38 MAPK is also involved in other neuronal processes, including stress-induced behavioral responses. "Although the cellular and molecular basis for these behavioral actions is not known, one possible site of action is the serotonergic neurons, because this transmitter system has a well-established role in the regulation of mood," explains study author Dr. Michael R. Bruchas. Dr. Bruchas, coauthor Dr. Charles Chavkin, and their colleagues at the University of Washington in Seattle studied the effects of p38alpha MAPK in serotonergic neurons in the dorsal raphe nucleus, the primary source of serotonin in the brain.

In mouse models of stress-induced depression-like behaviors, selective deletion of p38alpha MAPK from serotonin-producing neurons in the dorsal raphe nucleus resulted in mice that did not exhibit depression-like or drug-relapse-like behaviors in response to stress. This was in direct contrast to mice with typical p38alpha MAPK activity. The researchers went on to show that activation of p38alpha MAPK by kappa opioid receptors increased the rate of serotonin reuptake. These findings suggest that stress initiates a cascade of events in which p38alpha MAPK reduces the amount of serotonin available in the brain, leading to depression-like behaviors.

"Our data demonstrate that p38alpha expression in serotonin neural circuits is required for local regulatory control of serotonin transport that ultimately controls behavioral responses, including social avoidance, relapse of drug seeking, and the dysphoria-like responses," concludes Dr. Chavkin. "These results are important because they implicate a critical requirement for p38alpha MAPK signaling in serotonin neuronal function during stress and demonstrate that p38alpha MAPK, in spite of its ubiquitous expression profile, has the ability to specifically regulate selected downstream targets to shape behavioral output. Further, activation of this system by kappa opioid receptors may represent a novel therapeutic target to promote stress resilience."

Source: Cell Press